What is Daxen?
Founded in 1993 by Datuk Lim Siow Jin, DXN (Daxen) is a global entity specializing in Ganoderma-based health food supplements. The company operates a vertically integrated model, encompassing cultivation, manufacturing, and distribution. Its product portfolio spans dietary supplements, food and beverages, personal care, skin care, and household items. DXN has cultivated an extensive network of over 20 million registered distributors across more than 180 countries, operating under a 'One World One Market' philosophy that enables international business with a single membership. The company's mission is to foster both health and financial independence among its members, a goal supported by its innovative marketing strategies and commitment to quality, which have garnered numerous industry accolades.
How much funding has Daxen raised?
Daxen has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
What's next for Daxen?
The recent large-scale, late-stage funding signifies a pivotal moment for Daxen, likely enabling the company to accelerate its global expansion, enhance its product development pipeline, and further solidify its distribution network. This strategic investment suggests confidence from backers in DXN's proven business model and its capacity for sustained growth in the competitive health and wellness sector. Future initiatives may focus on leveraging technology to optimize its extensive distributor network and potentially exploring new market segments or product innovations.
See full Daxen company page
